Mid-Year Report

GILBERT'S LLP for MYLAN LABORATORIES INC

Firm
Client
Income
$180,000
Expenses
—

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Enforcement and possible reform of the legislation and regulations relating to drug approval

LobbyistCovered position, as disclosed
NAWEL BAILEY N/A
TIM GILBERT N/A

Contacted: Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Enforcement and possible reform of the legislation and regulations relating to drug approval

LobbyistCovered position, as disclosed
NAWEL BAILEY N/A
TIM GILBERT N/A

Contacted: HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); SENATE

Health Issues HCR

Enforcement and possible reform of the legislation and regulations relating to drug approval

LobbyistCovered position, as disclosed
NAWEL BAILEY N/A
TIM GILBERT N/A

Contacted: Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; SENATE

Foreign Relations FOR

Enforcement and possible reform of the legislation and regulations relating to drug approval

LobbyistCovered position, as disclosed
NAWEL BAILEY N/A
TIM GILBERT N/A

Contacted: Federal Trade Commission (FTC); SENATE; HOUSE OF REPRESENTATIVES

Consumer Issues/Safety/Products CSP

Enforcement and possible reform of the legislation and regulations relating to drug approval

LobbyistCovered position, as disclosed
NAWEL BAILEY N/A
TIM GILBERT N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Federal Trade Commission (FTC)

Government Issues GOV

Enforcement and possible reform of the legislation and regulations relating to drug approval

LobbyistCovered position, as disclosed
NAWEL BAILEY N/A
TIM GILBERT N/A

Contacted: SENATE; Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.